Dosage form: capsule, delayed release
Drug class:Macrolides
Medically reviewed by Drugs.com. Last updated on Feb 21, 2022.
On This Page
Rx only
To reduce the development of drug-resistant bacteria and maintain the effectiveness of Erythromycin Delayed-release Capsules, USP and other antibacterial drugs, Erythromycin Delayed-release Capsules, USP should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria.
Erythromycin Capsules Description
Erythromycin Delayed-release Capsules, USP contain enteric-coated pellets of erythromycin base for oral administration.
Each Erythromycin Delayed-release Capsule, USP contains 250 mg of erythromycin base.
Inactive Ingredients
Cellulosic polymers, citrate ester, D&C Red No. 30, D&C Yellow No. 10, magnesium stearate and povidone. The capsule shell contains FD&C Blue No. 1, FD&C Red No. 3, gelatin, and titanium dioxide.
Erythromycin is produced by a strain of Saccharopolyspora erythraea (formerly Streptomyces erythraeus) and belongs to the macrolide group of antibiotics. It is basic and readily forms salts with acids but it is the base which is microbiologically active. Erythromyc...
